General Archive

Home » Neurodegeneration
  • Amyloid plaques aggregates, 3d illustration
    News releases

    Two major UK decisions announced on use of Alzheimer’s drug, lecanemab

    Today, two major decisions have been made on lecanemab (Leqembi®) – the Alzheimer’s drug that we helped humanise, which slows the…

    Read more

  • 3D illustration of a synapse and Neuron cells sending electrical chemical signals.

    NEURii

    Transforming care for people living with dementia through UK-based collaboration, NEURii.  In partnership with Eisai, Gates Ventures, Health Data Research…

    Read more

  • A male LifeArc scientists wearing gloves, a lab coat and safety glasses, pipettes liquid into a clear beaker.

    £30m partnership with UK DRI

    £30m partnership with UK Dementia Research Institute The partnership will accelerate development of new treatments for people with dementia. Partnership…

    Read more

  • A portrait of Roger Barker.
    News releases

    LifeArc appoints new chair for neurodegeneration efforts

    Today, we’re pleased to announce the appointment of Professor Roger Barker as Chair of our neurodegeneration efforts. Professor Barker is…

    Read more

  • News releases

    Seven neurodegeneration research projects receive £14.5m from LifeArc-UKDRI partnership

    The first projects to be funded through LifeArc’s £30 million strategic partnership with the UK Dementia Research Institute (UKDRI) have…

    Read more

  • Close-up of CT scan with brain.
    News releases

    LifeArc helps fund new research institute to accelerate the search for a cure for MND

    A new research institute to accelerate the search for a cure for motor neuron disease (MND, also known as ALS),…

    Read more

  • Close-up of CT scan with brain.
    Articles & blogs

    New Alzheimer’s treatment ‘lecanemab’ approved for use in the US

    LifeArc played an instrumental role in the drug’s development through our antibody humanisation work.

    Read more

  • Amyloid plaques aggregates, 3d illustration
    News releases

    New UK-based research project brings together world-leading institutions to transform care for people living with dementia

    Brings together the world-leading expertise of Health Data Research UK, University of Edinburgh, LifeArc, Eisai and Gates Ventures

    Read more

  • 3D illustration of a neuron in beautiful background
    Articles & blogs

    How LifeArc’s Neurodegeneration Translational Challenge is leading the charge against Motor Neurone Disease

    June 21st is Global MND Awareness Day, a day to raise worldwide awareness of MND (Motor Neurone Disease) and to…

    Read more

  • Dr David Powell, Chief Scientific Officer at LifeArc
    Articles & blogs

    Alzheimer’s drug lecanemab approved by US regulator

    LifeArc’s Chief Scientific Officer Dr Dave Powell comments on news that lecanemab has received regulatory and safety approval from the…

    Read more

  • Photo of older woman with her carer
    Articles & blogs

    LifeArc plays key role in discovery of new Alzheimer’s treatment

    LifeArc played an important part in the discovery of lecanemab, an experimental drug that has shown some benefits for people…

    Read more

  • Older patient with carer
    News releases

    New £30 million translational partnership will accelerate development of new treatments for people with dementia

    Funding will accelerate development of new diagnostic tests, treatments, and devices for people with dementia.

    Read more